Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100049609Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial in gastrointestinal conditions comparing ciprofol + alfentanil with propofol + alfentanil (2 arms). Primary endpoints: Incidence of intraoperative adverse events and Anesthesia recovery time. Planned start Aug 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100049609.